Print reports portrayed Medicare drug price reform as problematic for Democrats, ignoring internal drug memo laying out industry concerns

SUMMARY: The Washington Post, the Los Angeles Times, and The Wall Street Journal all asserted that it may be difficult for congressional Democrats to deliver on their pledge to reform the Medicare drug plan over the opposition of the Bush administration, congressional Republicans, and the pharmaceutical industry, but did not report an internal drug company memo that warned of bills that would allow imported drugs and force price competition.

Comments